ENERGY: Reducing Breast Cancer Recurrence With Weight Loss
Study Details
Study Description
Brief Summary
The purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible, and have an impact on body weight, quality of life and fatigue. Since obesity among breast cancer survivors is associated with recurrence and other co-morbidities, those will be assessed and their impact calculated. Blood samples will be collected to enable analysis of potential mechanisms and differential response across subgroups.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Less Intensive Group Participants in this group would receive print materials on diet and exercise and two individual counseling sessions; one at the beginning of the study and another 6 months later. |
Behavioral: Less Intensive
Participants in this group would receive print materials on diet and exercise and two individual counseling sessions; one at the beginning of the study and another 6 months later.
|
Experimental: Intensive Group Participants in this group would receive print materials on diet and exercise and attend group sessions that would meet weekly for the first 4 months, then every two weeks for the next 2 months, and then monthly for the next 6 months over the course of one year. |
Behavioral: Intensive Group
Participants in this group would receive print materials on diet and exercise and attend group sessions that would meet weekly for the first 4 months, then every two weeks for the next 2 months, and then monthly for the next 6 months over the course of one year.
|
Outcome Measures
Primary Outcome Measures
- Weight loss [2 years]
Secondary Outcome Measures
- Improvement in quality of life [2 years]
- Improvement in fatigue [2 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of breast cancer (stages I (≥1 cm), stage II, or stage IIIA, B, C excluding distant metastasis) diagnosed between 6 months and 5 years earlier; after initial therapies are completed, diagnosed between six months and five years earlier
-
BMI between 25 to 45 kg/m2
-
Able to comply with all required study procedures and schedule
Exclusion Criteria:
-
Serious medical condition or psychiatric illness
-
Inability to be moderately physically active
-
Obesity of known endocrine origin (e.g., untreated hypothyroidism, PCOS)
-
Currently enrolled in a weight loss program
-
Current use of weight loss medication or supplements
-
Previous surgical procedures for weight reduction
-
Planning weight loss surgery in the next 2 years.
-
6+ months use of meds likely to cause weight gain or prevent weight loss
-
Planned surgical procedure that can impact the conduct of the study
-
Currently pregnant/breastfeeding
-
Planning to become pregnant within the next 2 years
-
Have plans to relocate from area within 2 years
-
Family relative or close friend is a trial staff member or a study participant
-
Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion in this study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alabama at Birmingham | Birmingham | Alabama | United States | 35294-3360 |
2 | Moores UCSD Cancer Center | La Jolla | California | United States | 92093 |
3 | University of Colorado Denver | Aurora | Colorado | United States | 80045 |
4 | Washington University in St. Louis: | St. Louis | Missouri | United States | 63110 |
Sponsors and Collaborators
- University of California, San Diego
- Washington University School of Medicine
- University of Colorado, Denver
- University of Alabama at Birmingham
Investigators
- Principal Investigator: Cheryl L. Rock, PhD, RD, University of California, San Diego
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CA148791-01